End-diastolic volume
End-diastolic volume (EDV) is a term used in cardiology to describe the volume of blood in the ventricles of the heart at the end of diastolic filling, just before systole (the contraction of the heart muscle). It is a key parameter in assessing the heart's function, particularly in relation to its pumping efficiency and health. EDV, along with end-systolic volume (ESV), is used to calculate the ejection fraction (EF), a critical measure of heart efficiency.
Physiology
During the diastole phase of the cardiac cycle, the heart ventricles relax and fill with blood. This period of relaxation and filling culminates in the end-diastolic volume. The volume of blood in the ventricles at this point is crucial for determining the subsequent stroke volume (SV) — the amount of blood ejected from the heart during systole. According to the Frank-Starling law of the heart, the stroke volume increases in response to an increase in the volume of blood filling the heart (the end-diastolic volume), up to a point. This relationship underscores the importance of EDV in cardiac function.
Measurement
End-diastolic volume can be measured using various imaging techniques, including echocardiography, cardiac MRI (magnetic resonance imaging), and cardiac CT (computed tomography). Echocardiography, a non-invasive and widely available method, uses ultrasound waves to create images of the heart, allowing for the measurement of EDV and other cardiac parameters.
Clinical Significance
Alterations in end-diastolic volume can indicate various cardiac conditions. An increased EDV may suggest heart failure, cardiomyopathy, or valvular heart disease, as these conditions can impair the heart's ability to pump blood efficiently, leading to an accumulation of blood in the ventricles. Conversely, a decreased EDV may be seen in conditions like dehydration or hemorrhage, where there is a reduction in the volume of circulating blood.
Treatment and Management
Management of abnormal end-diastolic volume focuses on treating the underlying cause. For instance, in the case of heart failure, treatment may include medications such as ACE inhibitors, beta blockers, and diuretics to improve heart function and control blood volume. Lifestyle modifications, including diet and exercise, may also be recommended to improve cardiovascular health.
See Also

This article is a cardiovascular system stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian